The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status
Table 1
General overview of the clinicopathological features according to HER2-low and HER2-negative subtypes belonging.
HER2 status
HER2 low (%)
HER2 negative (%)
Age
0.3
<50yo
46.4
47.4
>50yo
53.6
52.6
SBR grade
<0.001
I
38.8
18.0
II
38.2
49.8
III
19.8
28.7
NA
3.1
3.4
Tumor size
<0.001
T0
0.0
0.5
T1
17.4
21.8
T2
29.4
41.6
T3
8.0
7.8
T4
1.3
7.3
TX
43.8
21.1
Lymph node
<0.001
N+
45.1
51.0
N0
36.6
40.7
NX
18.4
8.3
Tumor stage
<0.001
I
8.7
10.9
II
17.8
32.4
III
20.0
28.3
IV
1.0
3.0
NA
52.4
25.4
ER
0.2
Negative
19.2
20.3
Positive
80.8
79.7
PR
0.1
Negative
24.1
26.9
Positive
75.9
72.9
NA
0.0
0.2
Ki67
<0.001
<20%
32.5
38.4
>20%
57.5
45.6
NA
10.0
16.0
The values in bold presented in Table 1 indicate that the p value is less than 0.05.